Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma
- PMID: 26823701
- PMCID: PMC4713487
Zinc finger protein x-linked (ZFX) contributes to patient prognosis, cell proliferation and apoptosis in human laryngeal squamous cell carcinoma
Abstract
Zinc finger protein, X-linked (ZFX) gene locus on the human X chromosome is structurally similar to the zinc finger protein, Y-linked gene. Its role in human laryngeal squamous cell carcinoma (LSCC) is still not clearly defined. This study was focused on investigating the role of zinc-finger protein X-linked (ZFX) in human LSCC. Expression levels of ZFX were examined in LSCC tissues, corresponding adjacent non-tumoral tissues and vocal leukoplakia tissues by immunohistochemistry (IHC). The association with the expression level of ZFX and LSCC clincopathological parameters was analyzed. The prognostic value of ZFX expression was also analyzed. Lentivirus-mediated RNA interference was applied to silence ZFX expression and the effects of ZFX knockdown on the growth of human LSCC primary cells was investigated. Overexpression of ZFX was found in LSCC tissues. The expression of ZFX was associated with the clinical stage of LSCC. Patients with higher level of ZFX experienced a poorer prognosis compared to those with lower level of ZFX. Knockdown of ZFX inhibited cell proliferation, colony formation and migration of LSCC primary cells. Moreover, ZFX silencing induced cell apoptosis. These results provide the convincing evidence for the first time that ZFX plays an important role in LSCC development and could be a potential therapeutic target or prognostic predictor for LSCC.
Keywords: Laryngeal squamous cell carcinoma (LSCC); apoptosis; prognosis; proliferation; zinc finger protein x-linked (ZFX).
Figures







Similar articles
-
Knockdown of zinc finger protein, X-linked (ZFX) inhibits cell proliferation and induces apoptosis in human laryngeal squamous cell carcinoma.Mol Cell Biochem. 2012 Jan;360(1-2):301-7. doi: 10.1007/s11010-011-1069-x. Epub 2011 Oct 19. Mol Cell Biochem. 2012. PMID: 22009483
-
SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.Oncol Rep. 2017 Nov;38(5):3019-3029. doi: 10.3892/or.2017.5976. Epub 2017 Sep 20. Oncol Rep. 2017. PMID: 29048627
-
Long non-coding RNA CCAT1/miR-218/ZFX axis modulates the progression of laryngeal squamous cell cancer.Tumour Biol. 2017 Jun;39(6):1010428317699417. doi: 10.1177/1010428317699417. Tumour Biol. 2017. PMID: 28631575
-
Long Non-coding RNAs as Important Biomarkers in Laryngeal Cancer and Other Head and Neck Tumours.Int J Mol Sci. 2019 Jul 12;20(14):3444. doi: 10.3390/ijms20143444. Int J Mol Sci. 2019. PMID: 31336999 Free PMC article. Review.
-
High Gpx1 expression predicts poor survival in laryngeal squamous cell carcinoma.Auris Nasus Larynx. 2018 Feb;45(1):13-19. doi: 10.1016/j.anl.2017.05.012. Epub 2017 Jun 20. Auris Nasus Larynx. 2018. PMID: 28641905 Review.
Cited by
-
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.Endocr Rev. 2023 Sep 15;44(5):779-818. doi: 10.1210/endrev/bnad009. Endocr Rev. 2023. PMID: 36961765 Free PMC article.
-
Blockade of ZFX Alleviates Hypoxia-Induced Pulmonary Vascular Remodeling by Regulating the YAP Signaling.Cardiovasc Toxicol. 2024 Feb;24(2):158-170. doi: 10.1007/s12012-023-09822-5. Epub 2024 Feb 3. Cardiovasc Toxicol. 2024. PMID: 38310188
-
A 14-Marker Multiplexed Imaging Panel for Prognostic Biomarkers and Tumor Heterogeneity in Head and Neck Squamous Cell Carcinoma.Front Oncol. 2021 Aug 19;11:713561. doi: 10.3389/fonc.2021.713561. eCollection 2021. Front Oncol. 2021. PMID: 34490110 Free PMC article.
References
-
- Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008;41:673–95. - PubMed
-
- Lin HW, Bhattacharyya N. Staging and survival analysis for nonsquamous cell carcinomas of the larynx. Laryngoscope. 2008;118:1003–13. - PubMed
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96. - PubMed
-
- Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006;116(Suppl 111):1–13. - PubMed
-
- Wu S, Lao XY, Sun TT, Ren LL, Kong X, Wang JL, Wang YC, Du W, Yu YN, Weng YR, Hong J, Fang JY. Knockdown of ZFX inhibits gastric cancer cell growth in vitro and in vivo via downregulating the ERK-MAPK pathway. Cancer Lett. 2013;337:293–300. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical